Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon purchased 12 shares of the stock in a transaction that occurred on Wednesday, April 15th. The shares were purchased at an average price of GBX 2,022 per share, for a total transaction of £242.64.
Liam Condon also recently made the following trade(s):
- On Wednesday, March 11th, Liam Condon purchased 14 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 1,941 per share, for a total transaction of £271.74.
- On Monday, February 23rd, Liam Condon purchased 5,226 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 1,923 per share, for a total transaction of £100,495.98.
- On Wednesday, February 11th, Liam Condon purchased 10 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 2,342 per share, for a total transaction of £234.20.
Johnson Matthey Stock Up 0.8%
Shares of JMAT opened at GBX 2,036 on Thursday. The stock has a market cap of £3.41 billion, a price-to-earnings ratio of -30.90, a P/E/G ratio of 49,242.50 and a beta of 0.90. The company has a quick ratio of 0.76, a current ratio of 1.65 and a debt-to-equity ratio of 71.01. Johnson Matthey PLC has a 12 month low of GBX 1,183 and a 12 month high of GBX 2,434. The company has a 50-day moving average price of GBX 2,026.10 and a two-hundred day moving average price of GBX 2,107.19.
Wall Street Analysts Forecast Growth
JMAT has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the stock a "buy" rating in a research note on Tuesday, April 7th. Berenberg Bank decreased their price objective on shares of Johnson Matthey from GBX 2,250 to GBX 2,100 and set a "buy" rating on the stock in a research note on Monday, March 23rd. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Johnson Matthey currently has an average rating of "Moderate Buy" and a consensus price target of GBX 2,222.
Check Out Our Latest Report on Johnson Matthey
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.